272 related articles for article (PubMed ID: 33827458)
1. Differences in antibiotic and antiviral use in people with confirmed influenza: a retrospective comparison of rapid influenza PCR and multiplex respiratory virus PCR tests.
Au Yeung V; Thapa K; Rawlinson W; Georgiou A; Post JJ; Overton K
BMC Infect Dis; 2021 Apr; 21(1):321. PubMed ID: 33827458
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial prescribing after rapid influenza PCR implementation in the emergency department.
Wesolowski A; Miller JL; Shields M; Dela-Pena J
Am J Emerg Med; 2023 Sep; 71():123-128. PubMed ID: 37390608
[TBL] [Abstract][Full Text] [Related]
3. A pragmatic randomized controlled trial of rapid on-site influenza and respiratory syncytial virus PCR testing in paediatric and adult populations.
Bibby HL; de Koning L; Seiden-Long I; Zelyas N; Church DL; Berenger BM
BMC Infect Dis; 2022 Nov; 22(1):854. PubMed ID: 36384484
[TBL] [Abstract][Full Text] [Related]
4. Impact of multiplex molecular assay turn-around-time on antibiotic utilization and clinical management of hospitalized children with acute respiratory tract infections.
Lee BR; Hassan F; Jackson MA; Selvarangan R
J Clin Virol; 2019 Jan; 110():11-16. PubMed ID: 30502640
[TBL] [Abstract][Full Text] [Related]
5. Clinical Utility of On-Demand Multiplex Respiratory Pathogen Testing among Adult Outpatients.
Green DA; Hitoaliaj L; Kotansky B; Campbell SM; Peaper DR
J Clin Microbiol; 2016 Dec; 54(12):2950-2955. PubMed ID: 27654334
[TBL] [Abstract][Full Text] [Related]
6. Influenza-associated mortality in hospital care: a retrospective cohort study of risk factors and impact of oseltamivir in an English teaching hospital, 2016 to 2017.
Reacher M; Warne B; Reeve L; Verlander NQ; Jones NK; Ranellou K; Christou S; Wright C; Choudhry S; Zambon M; Sander C; Zhang H; Jalal H
Euro Surveill; 2019 Oct; 24(44):. PubMed ID: 31690364
[TBL] [Abstract][Full Text] [Related]
7. Contribution of the FilmArray Respiratory Panel in the management of adult and pediatric patients attending the emergency room during 2015-2016 influenza epidemics: An interventional study.
Busson L; Bartiaux M; Brahim S; Konopnicki D; Dauby N; Gérard M; De Backer P; Van Vaerenbergh K; Mahadeb B; Mekkaoui L; De Foor M; Wautier M; Vandenberg O; Mols P; Levy J; Hallin M
Int J Infect Dis; 2019 Jun; 83():32-39. PubMed ID: 30926539
[TBL] [Abstract][Full Text] [Related]
8. Point-of-Care Influenza Testing in the Pediatric Emergency Department.
Patel P; Laurich VM; Smith S; Sturm J
Pediatr Emerg Care; 2020 Nov; 36(11):515-518. PubMed ID: 33065674
[TBL] [Abstract][Full Text] [Related]
9. More targeted use of oseltamivir and in-hospital isolation facilities after implementation of a multifaceted strategy including a rapid molecular diagnostic panel for respiratory viruses in immunocompromised adult patients.
Vos LM; Weehuizen JM; Hoepelman AIM; Kaasjager KHAH; Riezebos-Brilman A; Oosterheert JJ
J Clin Virol; 2019 Jul; 116():11-17. PubMed ID: 30999234
[TBL] [Abstract][Full Text] [Related]
10. Effect of target-enriched multiplex polymerase chain reaction on patient outcomes and costs during the 2013-14 influenza season.
Hassoun A; Huff MD; Asis E; Chahal K; Azarbal A; Lu S
J Hosp Infect; 2017 Aug; 96(4):366-370. PubMed ID: 28571763
[TBL] [Abstract][Full Text] [Related]
11. Influenza Testing and Treatment Among Patients Hospitalized With Community-Acquired Pneumonia.
Deshpande A; Klompas M; Yu PC; Imrey PB; Pallotta AM; Higgins T; Haessler S; Zilberberg MD; Lindenauer PK; Rothberg MB
Chest; 2022 Sep; 162(3):543-555. PubMed ID: 35134384
[TBL] [Abstract][Full Text] [Related]
12. Implementation of a rapid influenza A/B and RSV direct molecular assay improves emergency department oseltamivir use in paediatric patients.
Mitchell SL; Chang YC; Feemster K; Cárdenas AM
J Med Microbiol; 2018 Mar; 67(3):358-363. PubMed ID: 29458688
[TBL] [Abstract][Full Text] [Related]
13. Assessment of Temporal Patterns and Patient Factors Associated With Oseltamivir Administration in Children Hospitalized With Influenza, 2007-2020.
Walsh PS; Schnadower D; Zhang Y; Ramgopal S; Shah SS; Wilson PM
JAMA Netw Open; 2022 Sep; 5(9):e2233027. PubMed ID: 36149655
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial Stewardship Optimization in the Emergency Department: The Effect of Multiplex Respiratory Pathogen Testing and Targeted Educational Intervention.
Durant TJS; Kubilay NZ; Reynolds J; Tarabar AF; Dembry LM; Peaper DR
J Appl Lab Med; 2020 Nov; 5(6):1172-1183. PubMed ID: 32918445
[TBL] [Abstract][Full Text] [Related]
15. Impact of rapid influenza PCR testing on hospitalization and antiviral use: A retrospective cohort study.
Chu HY; Englund JA; Huang D; Scott E; Chan JD; Jain R; Pottinger PS; Lynch JB; Dellit TH; Jerome KR; Kuypers J
J Med Virol; 2015 Dec; 87(12):2021-6. PubMed ID: 26017150
[TBL] [Abstract][Full Text] [Related]
16. Impact of rapid diagnosis on management of adults hospitalized with influenza.
Falsey AR; Murata Y; Walsh EE
Arch Intern Med; 2007 Feb; 167(4):354-60. PubMed ID: 17242309
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial.
Fry AM; Goswami D; Nahar K; Sharmin AT; Rahman M; Gubareva L; Azim T; Bresee J; Luby SP; Brooks WA
Lancet Infect Dis; 2014 Feb; 14(2):109-18. PubMed ID: 24268590
[TBL] [Abstract][Full Text] [Related]
18. Comparative efficacy assessment of antiviral alone and antiviral-antibiotic combination in prevention of influenza-B infection associated complications.
Ishaqui A; Hayat Khan A; Sulaiman SAS; Taher Alsultan M; Khan I
Expert Rev Anti Infect Ther; 2021 Sep; 19(9):1165-1173. PubMed ID: 33567928
[TBL] [Abstract][Full Text] [Related]
19. The association between influenza treatment and hospitalization-associated outcomes among Korean children with laboratory-confirmed influenza.
Lim JK; Kim TH; Kilgore PE; Aiello AE; Choi BM; Lee KC; Yoo KH; Song YH; Kim YK
J Korean Med Sci; 2014 Apr; 29(4):485-93. PubMed ID: 24753694
[TBL] [Abstract][Full Text] [Related]
20. Oseltamivir is protective for in-patient mortality in PCR confirmed influenza B and influenza A(H3N2) infections in an historic cohort of 1,048 patients hospitalised during the 2016-17 and 2017-18 influenza seasons.
Reacher M; Warne B; Verlander NQ; Popay A; Reeve L; Jones NK; Ranellou K; Sithole N; Carpenter R; Everden A; Jarman E; Khalid A; Lam K; Myers C; Ren S; Rolfe KJ; Sutton T; Christou S; Wright C; Choudhry S; Zambon M; Sander C; Zhang H; Jalal H
J Infect; 2023 Mar; 86(3):256-308. PubMed ID: 36646142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
